Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4700-4715
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4700
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4700
Figure 5 Matrine impedes proliferation, invasion and migration in colorectal cancer by downregulating shank-associated RH domain interactor.
A: The viability of colorectal cancer (CRC) cells using the cell counting kit-8 assay in 4 groups [control (con), si-Shank-associated RH domain interactor (SHARPIN), matrine, siSHARPIN + matrine]; B: The invasion cells of CRC in 4 groups; C: The wound healing of CRC cells in 4 groups. cP < 0.05 vs con,dP < 0.01 vs con; eP < 0.05 vs siSHARPIN,fP < 0.01 vs siSHARPIN; gP < 0.05 vs matrine,hP < 0.01 vs matrine; Con: Control group; SHARPIN: Shank-associated RH domain interactor; siSHARPIN: SHARPIN knockdown group; matrine: Matrine group; siSHARPIN + matrine: Matrine and SHARPIN knockdown group; CRC: Colorectal cancer.
- Citation: Zhou YC, Wang QQ, Zhou GYJ, Yin TF, Zhao DY, Sun XZ, Tan C, Zhou L, Yao SK. Matrine promotes colorectal cancer apoptosis by downregulating shank-associated RH domain interactor expression. World J Gastrointest Oncol 2024; 16(12): 4700-4715
- URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4700.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4700